(Reuters) – The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk (NYSE:NVO)’s blockbuster weight-loss drug Wegovy.Here’s what Wall Street analysts say about the inclusion: WHAT IT

Investing.com — WW International (NASDAQ:WW) Inc. has initiated discussions to address the company’s balance sheet issues, according to Bloomberg, citing sources familiar with the situation. The company, known for its WeightWatchers brand and diet-related products and services, is facing increased

Investing.com — Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial difficulties, originally acquired the virtual care startup in 2021 for $400 million in

WASHINGTON (Reuters) – The Biden administration on Friday issued last-minute proposed rules to curb duty-free imports under the $800 “de minimis” threshold, denying the low-value shipments exemption for goods that are subject to other punitive U.S. tariffs. The move marks a

By Sabrina Valle, Arriana McLymore and Siddharth Cavale SAN FRANCISCO/NEW YORK (Reuters) – U.S. industry conferences, including a major San Francisco healthcare meeting, have stepped up security for attendees this year after a health insurance executive was murdered near a December